Breaking News
-
Tesla and JP Morgan Lead Friday Afternoon Market Cap Stock Movers
Market Highlights: Stock Movements on Friday On Friday, the market has exhibited significant activity, particularly among mega-cap and large-cap stocks.…
Read More » -
Fed Expected to Implement Two More Rate Cuts This Year, but Job Gains Alleviate Urgency
Investing.com — The Federal Reserve is still likely to implement two rate cuts this year. However, the urgency to reduce…
Read More » -
State Farm Mutual Acquires $1.8 Million in GATX Corp Shares
State Farm Mutual Automobile Insurance Co., a prominent shareholder in GATX Corp, has enhanced its stake in the transportation services…
Read More » -
Star Fashion Culture Debuts at $3.75, IPO Set at $4
Star Fashion Culture (STFS) debuted at $3.75 following its initial public offering (IPO), which was set at a price of…
Read More » -
Nordic Capital Reportedly Considering Sale and US IPO of Trustly – Bloomberg
Nordic Capital Considering Sale or IPO for Trustly Nordic Capital is reportedly exploring options for Trustly, which may include a…
Read More » -
Trade Desk Stock Reaches All-Time High of $117.28
In an impressive demonstration of market confidence, Trade Desk Inc. (NASDAQ: TTD) has reached an all-time high stock price of…
Read More » -
This Chip Company Has a Multi-Year $100-$125 Billion AI Opportunity, According to BofA
Bank of America analysts recently underscored Broadcom’s strong position in the AI sector, forecasting significant long-term potential. Following a meeting…
Read More » -
Scotiabank Launches Major Tech Coverage: Amazon and Google Excel, Meta Rated Neutral
Scotiabank has recently started covering three major technology companies: Google, Amazon, and Meta Platforms. The bank has assigned “Sector Outperform”…
Read More » -
Upstream Bio Debuts at $21.50 After IPO Pricing of $17
Upstream Bio (UPB) Begins Trading at $21.50, Initial Public Offering Priced at $17 Upstream Bio has launched its trading with…
Read More » -
Camp4 Therapeutics Debuts at $11.16 After IPO Priced at $11
Camp4 Therapeutics (CAMP) debuted on the market at a price of $11.16, following an initial public offering priced at $11.
Read More »